A series of studies have demonstrated that a chronic and low-grade inflammation, characterized by the elevated pro-inflammatory cytokines such as TNF-α and IL-6, exists in obese and type 2 diabetic patients (40, 41). The gene discussed is IL6; the disease is type 2 diabetes mellitus.